NCT05660083
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05660083
Title Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital Research Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
National Institute of Health Clinical Center RECRUITING Bethesda Maryland 20892 United States Details
Houston Methodist Neal Cancer Center RECRUITING Houston Texas 77030 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field